Clinical Trial Update: UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma [Phase 1]

View source ↗

Summary

A Phase 1 study of UCL70805F in CD70-positive advanced clear cell renal cell carcinoma is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• UCL70805F

Snippet

Sponsor: UTC Therapeutics Inc. | Conditions: CD70-positive Advanced Renal Clear Cell Carcinoma | Phase 1 | Status: NOT_YET_RECRUITING